Cell-based therapy for patients with vascular dementia

Psychogeriatrics

Volumn 11, Issue 2, 2011, Pages 113-115

  Taguchi, Akihiko ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Bone marrow derived immature cells; CD34 positive cells; Cell based therapy; Microcirculation; Vascular dementia

Indexed keywords

ALZHEIMER DISEASE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN CIRCULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD34 SELECTION; CELL THERAPY; CEREBROVASCULAR DISEASE; HEART INFARCTION; HUMAN; MOYAMOYA DISEASE; MULTIINFARCT DEMENTIA; NEOVASCULARIZATION (PATHOLOGY); PATIENT SAFETY; PRIORITY JOURNAL; SHORT SURVEY; STROKE PATIENT; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANIMALS; ANTIGENS, CD34; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; DEMENTIA, MULTI-INFARCT; DEMENTIA, VASCULAR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROGENESIS;

EID: 79959729791     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/j.1479-8301.2010.00343.x     Document Type: Short Survey

References (20)

1. Asahara T, Murohara T, Sullivan A etal. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
2. Majka M, Janowska-Wieczorek A, Ratajczak J etal. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001; 97: 3075-3085.
3. Hill JM, Zalos G, Halcox JP etal. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
4. Taguchi A, Matsuyama T, Moriwaki H etal. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004; 109: 2972-2975.
5. Schmidt-Lucke C, Rossig L, Fichtlscherer S etal. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-2987.
6. Werner N, Kosiol S, Schiegl T etal. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
7. Werner N, Wassmann S, Ahlers P etal. Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007; 102: 565-571.
8. Yoshihara T, Taguchi A, Matsuyama T etal. Increase in circulating CD34-positive cells in patients with angiographic evidence of moyamoya-like vessels. J Cereb Blood Flow Metab 2008; 28: 1086-1089.
9. Taguchi A. Vascular factors in diabetes and Alzheimer's disease. J Alzheimers Dis 2009; 16: 859-864.
10. Taguchi A, Matsuyama T, Nakagomi T etal. Circulating CD34-positive cells provide a marker of vascular risk associated with cognitive impairment. J Cereb Blood Flow Metab 2008; 28: 445-449.
11. Taguchi A, Nakagomi N, Matsuyama T etal. Circulating CD34-positive cells have prognostic value for neurologic function in patients with past cerebral infarction. J Cereb Blood Flow Metab 2009; 29: 34-38.
12. Kawamoto A, Gwon HC, Iwaguro H etal. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103: 634-637.
13. Asahara T, Masuda H, Takahashi T etal. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228.
14. Taguchi A, Soma T, Tanaka H etal. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004; 114: 330-338.
15. Taguchi A, Ohtani M, Soma T etal. Therapeutic angiogenesis by autologous bone-marrow transplantation in a general hospital setting. Eur J Vasc Endovasc Surg 2003; 25: 276-278.
16. Tateishi-Yuyama E, Matsubara H, Murohara T etal. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-435.
17. Schachinger V, Erbs S, Elsasser A etal. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-1221.
18. Assmus B, Honold J, Schachinger V etal. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006; 355: 1222-1232.
19. Schachinger V, Erbs S, Elsasser A etal. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006; 27: 2775-2783.
20. Taguchi A, Zhu P, Cao F etal. Reduced ischemic brain Injury by partial rejuvenation of bone marrow cells in aged rats. J Cereb Blood Flow Metab 2010; in press: Epub 22 September 2010; doi: 10.1038/jcbfm.2010.165.